Keynote Speakers

Prof. Shaheen Mehtar

 

Prof Shaheen Mehtar is an Emeritus Professor at the Unit for Infection Prevention and Control (UIPC),  Faculty of Medicine & Health Sciences, Stellenbosch University. She trained in the United Kingdom in Medical Microbiology, and was Head of Microbiology at the North Middlesex Hospital & Senior Lecturer at Royal Free Hospital until 2000 when, she moved to South Africa.  In 2004 established the Unit of Infection Prevention and Control, Tygerberg Hospital & Stellenbosch Uni, and has trained more than 1000 students ranging from basic courses to a Masters in IPC across 34 countries in Africa.

She is an internationally recognised expert in IPC and has been instrumental in setting up IPC programmes globally. She served on the executive committees of HIS, BSAC, ESCMID, ISC and ISID. She serves on several WHO committees for global IPC policies.

Shaheen is a founder member, and Past Chair, of the Infection Control Africa Network (ICAN) through which she is involved in IPC, WASH and AMR training across Africa and setting up national IPC structures in 8 African countries. She was actively involved in Sierra Leone during the Ebola outbreak. She has published extensively (170 papers), authored two books and several chapters.


Julie Storr RGN BNurse MBA

Authentic leadership and the future of IPC

This session will focus on leadership for effective IPC with a special exploration of authentic leadership theory and its relevance to the infection preventionist. To support our understanding of what makes an effective IPC leader, the session will explore relevant literature on leadership challenges and opportunities including how to build capacity and capability. The session will draw on current thinking that shaped recent WHO IPC and quality handbooks and training resources – resources that support those responsible for leading the development and implementation of national and health care facility IPC and quality activities, policies, strategies and operational plans. The session will conclude with some personal reflections on a leadership journey in the quest for high quality people-centered IPC.

Patient empowerment 1999-2019

The role of patient empowerment in the prevention and control of infection has been on the table for over twenty years and has been described as a critical element of hand hygiene promotion. It has also been the subject of much academic debate with many questioning its value and feasibility. 2019 marks the twentieth anniversary of my own personal journey into patient empowerment and this session will look back on what has been learned since 1999. I will argue that the concept is perhaps, to some extent, misunderstood and will put forward the case that, as part of a multimodal strategy it can add tremendous value to the quest for zero avoidable infections and enhanced health related quality of life for patients.

 Julie is a graduate nurse from the University of Manchester, where she also trained as a Health Visitor and more recently studied for an MBA. Julie is a director at S3 Global and has over a decade of experience working with WHO on the development, implementation and evaluation of global improvement programmes in the field of patient safety, quality and infection prevention and control, with a focus on behaviour change. Julie has worked with WHO units focused on Water Sanitation and Health (WASH), Quality Systems and Resilience and Global Infection Prevention and Control (IPC). Her technical and leadership expertise was called on to support WHO’s Ebola response and recovery efforts in 2014/15, with a focus on national IPC policy development in Sierra Leone. She has led on the development of evidence based WHO Guidelines (Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level, 2016) and implementation support packages (Core Components and CRO). She was previously President of the Infection Prevention Society of the UK and Ireland, Assistant Director at the English National Patient Safety Agency and Director of the seminal cleanyourhands campaign. Julie has authored a book (Perspectives and Perceptions of IPC – highly commended at the 2016 BMA Medical Book Awards), published widely in the academic literature and is currently writing a follow up book focused on IPC and the social sciences. She is peer reviewer of a range of academic journals. One of her recent papers on infection prevention and control and universal health coverage and quality was awarded research paper of the year in the Journal of Research in Nursing in 2017. She is currently studying for a doctorate in public health (health care leadership and management) at Johns Hopkins Bloomberg School of Public Health, Baltimore.


Siouxsie Wiles – Microbiologist

Antimicrobial resistance: The end of modern medicine?

Antibiotics are a cornerstone of modern medicine, used to treat infectious diseases and prevent infection in vulnerable patients. In 2014, the World Health Organization (WHO) described how antibiotic-resistant bacteria are present in every region of the world, including Aotearoa New Zealand. Within a decade, antibiotic resistance will make routine surgery, organ transplantation and cancer treatment life-threatening. The WHO director general at the time, Margaret Chan, called the issue “…the end of modern medicine as we know it”. In her talk, Siouxsie will explain how this crisis came about and discuss the efforts she and her lab are making to find new antibiotics.

Prevention is better than cure – studying pathogen transmission in the lab

Despite its importance, transmission is missing from almost all experimental models used to investigate how bacteria cause disease in their mammalian hosts. Whereas we humans can be infected by eating contaminated food, say, laboratory animals are invariably infected by being injected with large doses of bacteria grown in rich laboratory media. In other words, the transmission step is missing in the experiment! We have recently pioneered a novel model to experimentally investigate the transmission of an infectious gut bacterium, with the ability to manipulate the bacterium, the host, and the environment. In her talk, Siouxsie will explain what their experiments are revealing about pathogen transmissibility.

Sponsored by 

Associate Professor Siouxsie Wiles studied medical microbiology at the University of Edinburgh, UK and then did a PhD in microbiology at the Centre for Ecology and Hydrology in Oxford. She spent several years working at Imperial College London where her research won the inaugural UK award for the humane use of animals in scientific research. In 2009, Siouxsie was awarded a Sir Charles Hercus Fellowship from the Health Research Council of New Zealand and relocated to the University of Auckland, where she heads up the Bioluminescent Superbugs Lab. Siouxsie also has a keen interest in demystifying science for the public; she is a tweeter, blogger, podcaster, In 2017 she published her first book, ‘Antibiotic resistance: the end of modern medicine?’, and recently collaborated with her daughter to make a kid’s show about microbiology. Siouxsie has won numerous awards for her science communication efforts, including the Prime Minister’s Science Media Communication Prize, and Royal Society Te Apārangi’s Callaghan Medal. She was one of three finalists for the 2018 Kiwibank New Zealander of Year award and this year was appointed a member of the New Zealand Order of Merit for services to microbiology and science communication.

 

 

Speakers

 John Aitken

Crohn’s Disease: Bacteria never sleep, so look busy
CWDM are bacteria with absent or rudimentary cell structures. They exist as part of the life cycle of Mycobacterium species.  Dormant CWDM are characterised by low metabolic activity and replication. and increased resistance to host/environmental stresses, including antibiotic action.    Crohn’s disease is sometimes associated with the human carriage of CWDM, particularly members of the Mycobacterium avium Complex (MAC).
Reactivation of tuberculosis is also attributed to escape from dormancy.
Previous work by us suggested that carriage of dormant CWDM was ubiquitous in both IBD patients and healthy controls.  This raised the possibility that variant forms of CWDM may be present in IBD patients. Here we report the findings of three studies on patients diagnosed with IBD and on healthy human controls.
Using already existing methods in combination with newly developed media we were able to demonstrate the carriage of CWDM in samples from healthy controls and IBD patients. We were also able to demonstrate and provisionally characterise variant CWDM forms present in human blood and deep ileal tissue of IBD patients but not in controls. These variant forms produced metabolites capable of causing inflammation.
The detection of variant forms of CWDM present in IBD patients may be a reliable biomarker, and several confirmatory studies have followed our preliminary observations.
To confirm pathogenicity and identity of these isolates, we are continuing with molecular testing, including next generation sequencing (NGS) on extracted DNA. Pathogenicity studies will be necessary. Demonstration of a newly described CWDM, if confirmed, may require infection control risk assessments.


John is a 68 year old free-lance medical laboratory scientist, and worked in medical microbiology for public and private providers for 43 years. He also helped to set up and run an environmental testing laboratory in my “spare time”.  He currently operates a private research laboratory, Otakaro Pathways Ltd.
John is particularly interested in antimicrobial resistance, and emerging bacterial infectious diseases. Most of his work involves an understanding of the underlying relationships between microorganisms, plants, and animals.
He believes that a solution can only be found if the life cycle of the problem organism is completely understood. The rest will then follow.
His experience in bacteriology and my international research relationships with other medical laboratory scientists have been invaluable in the investigation of emerging pathogenic organisms.
As in most businesses, his work is directed towards financially and sustainable solutions to complex problems.
John is presently involved in research in four areas:

  1. The relationship between autoimmune diseases and Mycobacterium species.
  2. Bioremediation, particularly in relation to the use of naturally occurring microorganisms.
  3. Biodiscovery of new antibiotic compounds.

Josh Freeman

New Zealand CPE guidelines – 1 year on

In this talk Josh will provide an update on the national response to CPE and how the CPE IPC guidelines have contributed.  He will also seek to identify strengths and weaknesses of the national response and ongoing practical measures for local IPC teams and other stakeholders to focus on.

Josh Freeman is the Clinical Director of Microbiology at Canterbury DHB and was previously the Clinical Lead of the Hand Hygiene New Zealand Programme. He has a longstanding interest in infection prevention and in particular the transmission of resistant gram negative organisms. Currently he’s working on initiatives to improve implementation of NZ’s national response to the evolving epidemic of carbapenemase-producing Enterobacteriaceae (CPE).


Prof. Mary-Louise McLaws

Sponsored by 

 

What hand hygiene would be like if kids ran hospitals

Hand hygiene is the first infection prevention and control activity we learn in childhood during toilet training. We are asked to learn a new approach at nursing and medical school. Yet, better handwashing after patient contact and in-depth discussions with mothers and children support the view that our childhood training influences our ward based compliance. Compliance with the introduction of the World Health Organization My Five Moments for Hand Hygiene identify Moments 3, 4 and 5, after different contacts, is universally better complied than before contact, Moment 1. I will discuss behavioural theories we can use to overcome our entrenched childhood behaviours.

CLABSI – Why targeting a zero benchmark is flawed

The Pronovost aseptic insertion program was attributed to successfully reducing in CLABSIs to a median of zero CLABSI per 1000 line days in USA. All Intensive Care Units in New South Wales public hospitals introduced the Pronovost program and reduced CLABSIs by 60% and if we reached zero why is this threshold setting us up for failure?

Mary-Louise is Professor of Epidemiology, Healthcare Associated Infection and Infectious Diseases Control at The University of New South Wales (UNSW) Australia, the Water-Health Leader for the UNSW Global Water Institute and Deputy President of the UNSW Academic Board. Her clinical epidemiology research is focused in patient safety improvement programs.
Mary-Louise has focused her research program on surveillance and hand hygiene. She performed the first Australian prevalence survey healthcare associated infections in the mid-1980s and went on to develop the first standardised semi-automated surveillance system for healthcare associated infections on behalf of the NSW Ministry of Health. In the mid-2000s she was the WHO Advisor to China and Malaysia for the development of their national HAI surveillance systems. She was a contributor to the WHO Guidelines for Hand Hygiene and an advisor to the WHO First Global Patient Safety Challenge: Clean Care is Safer Care project. Mary-Louise holds membership to the World Health Organization (WHO) Technical Steering Committee for the Infection Prevention and Control Global Unit.
As honorary epidemiologist to NSW Clinical Excellence Commission she collaborated on the first Australian hand hygiene intervention Clean Care Saves Live that preceded the national program while supervising early Australian behavioural aspects of hand hygiene intervention. She also collaborated on the NSW Clinical Excellence Commission CLABSI intervention that aimed at reducing central line associated infections in 32 intensive care units by introducing an aseptic insertion approach. This was adopted by ANZICS and rolled out nationally. She also collaborated on the Sepsis Kills intervention that aimed at early detection and treatment of sepsis in 32 emergency departments. This intervention saved over 200 lives and was awarded the Global Sepsis Alliance in the Government Category and in 2017 the Medical Journal of Australia/MDA awarded the publication Best Research Paper.
Post-SARS she collaborated with the Health Bureau to review the response to the outbreak in Beijing. In preparation of pandemic influenza the Chief Medical Officer appointed Mary-Louise to review the Australian Infection Prevention Guidelines for Healthcare Workers for evidence-based recommendations. Her capacity building in patient safety in low-medium resource settings includes ICU projects in Turkey, haemodialysis in Vietnam, hand hygiene for crowded healthcare settings in Vietnam, needlestick injury surveillance in Taiwan, water-related health in Vanuatu and Mali and understanding antibiotic prescribing practices and use of antibiotic in the community and food animals in Cambodia.
Her most recent projects have contested the reliability and validity of the human auditing used in the Australian national hand hygiene program against automation and clinicians’ behaviour around compliance.

 

Dr Phil Schroeder and Kelly Robertson

Canterbury Primary Response Group (CPRG)

Managing Infectious Outbreaks – the Canterbury Collaborative Approach
The Canterbury Primary Response Group (CPRG) was formed in 2005 following the threats of SARS and avian influenza worldwide.  The possible impact of these virus’ alerted health care professionals that a community-wide approach was needed to manage and coordinate a response to any outbreak or potential outbreak.
Therefore CPRG took the responsibility to coordinate and manage the regional, out of hospital, planning and response coordination to annual influenza threats and the possible escalation to pandemic outbreaks.
This presentation will outline the bringing together of not only a wide range of health providers but also key community agencies to plan strategies and responses to infectious outbreaks. It will focus on what the group has learned during this journey and its future planning for seasonal influenza, and other possible infectious outbreaks.

Dr Phil Schroeder is a general practitioner with over 25 years’ experience as a rural GP initiating general practice services in the township of Rolleston, 20 kilometres South of Christchurch.
He became involved with CPRG, in 2005, when the district turned its attention to the H5N1 Avian Influenza threat.  This was exercised in full when H1N1 “Swine Flu” arrived in New Zealand in late April 2009 and Dr Schroeder headed the Primary Health Response in Canterbury where there was widespread use of flu centres to both treat and protect the Canterbury population.
Since then Phil has continued to provide clinical leadership for primary and community care in responding to both natural disasters and infectious outbreaks that the region have experienced.

 

Kelly Robertson is a Registered Nurse, with 40 years+ experience working in both the secondary and primary health care sectors. She is currently the Nursing Advisor for the Canterbury Primary Response Group (CPRG), and has been involved with CPRG since its inception in 2005.
Kelly was part of the planning and leadership team during the H1N1 (pdm09) outbreak and also lead the nursing team at the Central Flu Center during this time. She has continued to provide nursing leadership for the group, especially during the subsequent seismic events of 2010-2011 and 2016.

 

 

Lisa Sterling

Building resilience through change
This presentation explores the place of stress in modern living, the causes of it, and our default responses to it.  It focuses on understanding our responses to stressful events and the coping strategies we employ.  Also covered are the importance of de-escalation and self-care to prevent burn-out and build personal resilience.

 The presentation will allow delegates to:

  • Recognise and identify their own personal stressors
  • Use the Stress Escalator Tool to help visualise the elevating nature of stress
  • Identify the signs and symptoms of someone experiencing elevated and critical stress
  • Understand the need to be continually de-escalating
  • Incorporate practical strategies into everyday life to reduce stress and improve well-being

This presentation is interactive and shares practical ways to take ownership, be accountable and take responsibility for one’s own well-being and resilience.

Lisa Stirling works as a Staff Support Professional for Workplace Support.  Through this role Lisa provides support and assistance to individuals to improve their well-being within their work environment.  Support could include anything from anxiety and depression to family and relationship challenges, mental well-being and stress management.

Lisa is a sought-after workshop facilitator and adult educator who has led well-being and employment education workshops for various organisations including Canterbury District Health Board, Ministry of Social Development and Inland Revenue Department.

Lisa’s workshops are engaging, informative, practical and relevant.  She is personable and authentic and draws on her rich life experience.  Lisa is relatable and down to earth, has a great sense of humour and the ability to relay complex concepts into everyday language that people can grasp and implement into their daily lives.

Chris Vanderweg

Illness and recovery – Living to tell the tale

After a weekend away hunting, and thinking I was reasonably fit and healthy, nothing could have prepared him for what would unfold in the weeks and months ahead.  From the initial doctor’s visit, to the mother’s lifesaving instincts, the baffled experts and the prompt medivac.
In an induced coma on life support, he couldn’t respond to any questions or give any information that might help the medical team. His family who never left his bedside were the ones that had to endure the daily struggle of the updates from the ICU staff, see his body go through some horrific things and literally watch him fade away.  He’ll never forget the relief he could see on their faces when he was finally able to talk to them again after so many potential complications.
However, as we would learn, the road to recovery is a long and arduous one.

Chris is a 36 years old and self-employed engineer based near Ashburton, Mid-Canterbury.  He was born and raised in Mid-Canterbury, educated at Christchurch Boys High School, and qualified with a NZ Diploma in Mechanical Engineering from CPIT.
He is one of three siblings, an uncle to a niece and two nephews and enjoy making time for friends and family.
As a keen outdoorsman, with a passion for hunting, fishing, and the great outdoors which means he is often found up a mountain, down a river or out on a lake.  With an extensive background in agriculture, his business focusses on fabrication, manufacturing, design and consultation for the agricultural and general engineering industries.
Prior to falling ill in 2018, besides back surgeries, he had never been hospitilised for a serious medical condition and would consider myself to be in fairly good health.
He looks forward to sharing with you my experiences of before, during and after his illness, and he hopes what he shares will further your understanding from a patient’s perspective.

Holly Weale

Reprocessing in endoscopy
Information to come

Holly is the charge nurse manager of the gastrointestinal investigative unit (endoscopy) in Christchurch Hospital.  She trained and qualified as a nurse in the UK and only discovered a passion for gastroenterology nursing on my arrival to NZ in 2003.  She has recently gained a Masters in Health Science from the University of Otago and have completed and presented audits looking at the psychological services available for people living with inflammatory bowel disease.